Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.36 |
| ▸ | ACP3 | P15309 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | LAP3 | P28838 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CTSD | P07339 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | MMP12 | P39900 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9021319 | 0.90 | TSHR (0.40) | TSHRHTTL3MBTL1LMNAPOLB | |
| SCHEMBL8958927 | 0.87 | HPGD (0.43) | TSHRHTTL3MBTL1LMNAPOLB | |
| SCHEMBL8959136 | 0.86 | IDO1 (0.42) | TSHRHTTL3MBTL1LMNAPOLB | |
| SCHEMBL28479763 | 0.86 | IDO1 (0.42) | TSHRHTTL3MBTL1LMNAPOLB | |
| SCHEMBL4030757 | 0.86 | FDPS (0.43) | TSHRHTTL3MBTL1LMNAPOLB | |
| SCHEMBL6384988 | 0.86 | IDO1 (0.42) | TSHRHTTL3MBTL1HPGDALDH1A1 | |
| SCHEMBL8958923 | 0.86 | IDO1 (0.42) | HTTL3MBTL1LMNAALDH1A1MEN1 | |
| SCHEMBL11710711 | 0.86 | TSHR (0.53) | TSHRHTTL3MBTL1LMNACA2 | |
| SCHEMBL9169326 | 0.85 | ACP3 (0.40) | TSHRHTTL3MBTL1LMNAPOLB | |
| SCHEMBL9170265 | 0.83 | CYP1A2 (0.38) | TSHRHTTL3MBTL1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0561948-B1 | PHOSPHONIC ACID DERIVATIVES USEFUL AS ANTIINFLAMMATORY AGENTS | UPJOHN CO (US) | 1995-04-05 | — | — | EP | claimed |
| US-5360797-A | Bisphosphonic acid derivatives useful as anti-arthritic agents | THE UPJOHN COMPANY (US) | 1994-11-01 | — | — | US | claimed |
| WO-1992010504-A2 | PHOSPHONIC ACID DERIVATIVES USEFUL AS ANTIINFLAMMATORY AGENTS | THE UPJOHN COMPANY (US) | 1992-06-25 | — | — | WO | claimed |
| US-8574773-B2 | Battery electrolyte solutions containing aromatic phosphorus compounds | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-11-05 | — | — | US | disclosed |
| EP-1027398-B1 | LIGHT-EMITTING DENDRIMERS AND DEVICES | ISIS INNOVATION (GB) | 2004-06-09 | — | — | EP | disclosed |
| US-6720093-B2 | DEVICE INCORPORATING AS, OR IN, ITS LIGHT-EMITTING ELEMENT LUMINESCENT COMPOUND INCLUDING CONJUGATED DENDRITIC MOLECULAR STRUCTURE COMPRISING GROUPS SELECTED FROM ARYL AND HETEROARYL GROUPS AND ALKENYL GROUPS CONNECTED TO EACH OTHER | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2004-04-13 | — | — | US | disclosed |
| US-20030165716-A1 | Dendrimers according to present invention which can be used for incorporation into light emitting devices have core and/or branches comprising electroluminescent or charge-transporting chromophores (conjugated units) | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2003-09-04 | — | — | US | disclosed |
| US-6558818-B1 | Light-emitting dendrimers and devices | ISIS INNOVATION LTD. (GB) | 2003-05-06 | — | — | US | disclosed |
| EP-1027398-A1 | LIGHT-EMITTING DENDRIMERS AND DEVICES | ISIS INNOVATION LIMITED (GB) | 2000-08-16 | — | — | EP | disclosed |
| WO-1999021935-A1 | LIGHT-EMITTING DENDRIMERS AND DEVICES | ISIS INNOVATION LIMITED (GB) | 1999-05-06 | — | — | WO | disclosed |
| EP-0561948-B1 | PHOSPHONIC ACID DERIVATIVES USEFUL AS ANTIINFLAMMATORY AGENTS | UPJOHN CO (US) | 1995-04-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030165716-A1 | Dendrimers according to present invention which can be used for incorporation into light emitting devices have core and/or branches comprising electroluminescent or charge-transporting chromophores (conjugated units) | CLTB, CLTA, CLTC | TSHR 3801/4885HTT 2647/4885L3MBTL1 3232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.